Our study suggests that MYSM1 as a deubiquitinase is involved in up-regulation of ERα action, exerting epigenetic modifier and ERα stability maintainer to enhance antiestrogen insensitivity in ERα positive breast cancer. Here, ESR1 is linked to breast carcinoma.